Plain-English translation of NCT03188874 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large research registry and biobank for people with acute myeloid leukemia (AML), a serious blood cancer. Researchers are collecting blood, tissue, and medical information from thousands of patients to build a database that will help them learn more about how the disease develops and responds to treatment. Your participation helps create a valuable resource for current and future research.
Acute myeloid leukemia is a complex disease, and researchers need access to real patient information and biological samples to understand it better and develop better treatments. By building this registry, scientists can identify patterns and test new ideas to improve care for people with this condition.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate blood or tissue samples and allow researchers to access your medical records and treatment history. The study is ongoing and may involve periodic contact to update your information as your care continues. There are no specific experimental treatments or medications involved — this is purely a data and sample collection effort to support research.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Germany